SequelSEC

Privia Health Group, Inc. PRVA

Services-Health Services · CIK 0001759655 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$2.12B
Fiscal year ended 2025-12-31
Operating income
$34.24M
Fiscal year ended 2025-12-31
Free cash flow
Unavailable
Fiscal year ended 2025-12-31

Privia Health Group, Inc. (PRVA) reported revenue of $2.12B and net income of $22.92M for the fiscal year ended 2025-12-31. This page shows 7 annual periods of income statement, balance sheet and cash flow figures normalized from Privia Health Group, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Health Services.

Income

Privia Health Group, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue$2.12B$1.74B$1.66B$1.36B$966.22M$817.08M$786.36M
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating income$34.24M$16.98M$20.65M-$19.12M-$217.44M$25.38M$16.06M
Net income$22.92M$14.38M$23.08M-$8.58M-$188.23M$31.24M$8.24M
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 128.89Mshares 125.61Mshares 124.69Mshares 110.70Mshares 102.95Mshares 95.95Mshares 95.93M
Pretax income$43.94M$27.87M$29.02M-$18.58M-$218.51M$23.46M$9.15M
Income tax expense$14.21M$10.83M$7.99M-$6.52M-$27.86M-$7.44M$1.21M
Diluted EPS$0.18$0.11$0.19$-0.08$-1.83$0.33$0.09
Selling, general & administrative$165.29M$152.60M$134.32M$149.33M$278.63M$55.36M$50.98M
General & administrative$138.15M$126.16M$109.59M$129.59M$255.88M$44.02M$41.83M
Selling & marketing$27.14M$26.45M$24.73M$19.74M$22.75M$11.34M$9.16M

Balance

Privia Health Group, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Cash & equivalents$479.68M$491.15M$389.51M$347.99M$320.58M$84.63MUnavailable
Total assets$1.37B$1.14B$999.90M$792.81M$686.37M$328.97MUnavailable
Current assets$911.00M$834.82M$700.80M$551.96M$446.68M$190.08MUnavailable
Total liabilities$578.44M$452.34M$392.51M$273.76M$236.19M$185.32MUnavailable
Current liabilities$568.52M$449.15M$386.95M$264.27M$190.46M$146.94MUnavailable
Total equity incl. NCI$790.94M$683.45M$607.39M$519.05M$450.18M$143.65M$107.46M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivable$400.90M$316.18M$290.77M$189.60M$117.40M$99.12MUnavailable
Goodwill$209.84M$141.62M$138.75M$126.94M$127.94M$118.66MUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$7.97M$9.76M$7.88M$6.73M$2.97M$5.24MUnavailable

Cash flow

Privia Health Group, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Operating cash flow$163.40M$109.28M$80.78M$47.20M$55.06M$38.89M$24.36M
Capital expendituresUnavailableUnavailable$113.00K$104.00K$547.00K$380.00K$5.71M
Investing cash flow-$181.57M-$11.98M-$42.97M-$104.00K-$32.78M-$380.00K-$5.71M
Financing cash flow$6.70M$4.33M$3.70M-$19.68M$213.66M-$767.00K-$10.87M
Net change in cash-$11.46M$101.64M$41.52M$27.42M$235.94M$37.74M$7.78M
Stock-based compensation$71.07M$56.68M$37.10M$67.36M$253.53M$484.00K$207.00K
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$9.91M$7.27M$6.53M$4.57M$2.46M$1.84M$1.43M

Derived

Privia Health Group, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Free cash flowUnavailableUnavailableUnavailableUnavailable$54.51M$38.51M$18.65M
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating margin1.6%1.0%1.2%-1.4%-22.5%3.1%2.0%
FCF marginUnavailableUnavailableUnavailableUnavailable5.6%4.7%2.4%
SBC / revenue3.3%3.3%2.2%5.0%26.2%0.1%0.0%
Current ratio1.60x1.86x1.81x2.09x2.35x1.29xUnavailable
Revenue YoY growth22.3%4.7%22.2%40.4%18.3%3.9%Unavailable
Net margin1.1%0.8%1.4%-0.6%-19.5%3.8%1.0%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailable0.1%0.0%0.7%
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rate32.3%38.8%27.5%UnavailableUnavailable-31.7%13.2%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open PRVA in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-02-27View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-08View SEC filing

Companies in the same industry

ATPC DCGO INNV LDDD LFST NPLY OMDA PIII PNTG SRTA USPH VSEE

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.